Loading clinical trials...
Loading clinical trials...
The goal of this observational study focuses on understanding and addressing a subset of persistent neuropsychiatric symptoms occurring within 3 months after mild to moderate COVID-19 infection (COVID...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre for Addiction and Mental Health
NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more
NCT07523048 · Major Depressive Disorder (MDD)
NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more
NCT06932237 · Neuro-PASC, Long COVID
NCT07226661 · Major Depressive Disorder (MDD)
Centre for Addiction and Mental Health
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions